Sotrovimab Expanded Access Treatment Protocol (COVID-19)

Inclusion Criteria: * In the opinion of the investigator, meets the current Emergency Use Authorization (EUA) eligibility criteria for sotrovimab OR * patients currently hospitalized for a non-COVID-19 illness who acquire COVID-19 (nosocomial infection) and otherwise meets all the current EUA eligibility criteria Exclusion Criteria: * Hospitalized due to COVID-19 (excludes nosocomial infection) * Require oxygen therapy due to COVID-19, OR who require an increase in baseline oxygen flow rate due to COVID-19